Show simple item record

dc.contributor.authorColeman, R E
dc.contributor.authorWinter, M C
dc.contributor.authorCameron, D
dc.contributor.authorBell, R
dc.contributor.authorDodwell, D
dc.contributor.authorKeane, M M
dc.contributor.authorGil, M
dc.contributor.authorRitchie, D
dc.contributor.authorPassos-Coelho, J L
dc.contributor.authorWheatley, D
dc.contributor.authorBurkinshaw, R
dc.contributor.authorMarshall, S J
dc.contributor.authorThorpe, H
dc.date.accessioned2018-09-20T16:03:42Z
dc.date.available2018-09-20T16:03:42Z
dc.date.issued2010-03-16
dc.identifier.citationColeman, R E; Winter, M C; Cameron, D; Bell, R; Dodwell, D; Keane, M M; Gil, M; Ritchie, D; Passos-Coelho, J L; Wheatley, D; Burkinshaw, R; Marshall, S J; Thorpe, H (2010). The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer. British Journal of Cancer 102 (7), 1099-1105
dc.identifier.issn0007-0920,1532-1827
dc.identifier.urihttp://hdl.handle.net/10379/10844
dc.publisherSpringer Nature
dc.relation.ispartofBritish Journal of Cancer
dc.subjectanti-tumour activity
dc.subjectbreast cancer
dc.subjectchemotherapy
dc.subjectneoadjuvant
dc.subjectpathological response
dc.subjectzol
dc.subjectsurgical adjuvant breast
dc.subjectpreoperative chemotherapy
dc.subjectpathological assessment
dc.subjectsystemic therapy
dc.subjectdoxorubicin
dc.subjectbisphosphonates
dc.subjectdisease
dc.subjectcarcinoma
dc.subjectsurvival
dc.subjectissues
dc.titleThe effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
dc.typeArticle
dc.identifier.doi10.1038/sj.bjc.6605604
dc.local.publishedsourcehttp://www.nature.com/bjc/journal/v102/n7/pdf/6605604a.pdf
nui.item.downloads0


Files in this item

This item appears in the following Collection(s)

Show simple item record